Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0176 Transporter Info | ||||
Gene Name | SLC25A17 | ||||
Transporter Name | Peroxisomal membrane protein PMP34 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Colon cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in colon adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg06852309) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 5.30E-06; Z-score: -1.92E+00 | ||
Methylation in Case |
4.35E-01 (Median) | Methylation in Control | 5.20E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A17 in colon adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg22971191) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 3.01E-03; Z-score: -2.86E+00 | ||
Methylation in Case |
6.68E-01 (Median) | Methylation in Control | 7.52E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A17 in colon adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg21692194) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 3.11E-03; Z-score: 1.52E+00 | ||
Methylation in Case |
2.89E-01 (Median) | Methylation in Control | 2.38E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A17 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg00069417) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 4.77E-03; Z-score: 5.97E-01 | ||
Methylation in Case |
8.93E-01 (Median) | Methylation in Control | 8.74E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
5'UTR (cg06645921) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 5.83E-04; Z-score: -1.03E+00 | ||
Methylation in Case |
4.00E-01 (Median) | Methylation in Control | 5.01E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A17 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
TSS1500 (cg21575465) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 1.05E-03; Z-score: 9.32E-01 | ||
Methylation in Case |
7.95E-01 (Median) | Methylation in Control | 7.06E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A17 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
TSS1500 (cg01575408) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 1.75E-02; Z-score: -3.45E-01 | ||
Methylation in Case |
4.82E-02 (Median) | Methylation in Control | 5.20E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A17 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
TSS200 (cg01379969) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 1.73E-02; Z-score: -6.82E-01 | ||
Methylation in Case |
8.80E-02 (Median) | Methylation in Control | 1.02E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A17 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
Body (cg16134515) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 4.09E-09; Z-score: 1.99E+00 | ||
Methylation in Case |
5.63E-01 (Median) | Methylation in Control | 5.08E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in bladder cancer | [ 3 ] | |||
Location |
TSS1500 (cg15275890) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 9.35E-06; Z-score: -1.12E+01 | ||
Methylation in Case |
6.55E-01 (Median) | Methylation in Control | 8.26E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A17 in bladder cancer | [ 3 ] | |||
Location |
Body (cg10954454) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 4.27E-11; Z-score: -9.72E+00 | ||
Methylation in Case |
5.90E-01 (Median) | Methylation in Control | 6.73E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A17 in bladder cancer | [ 3 ] | |||
Location |
Body (cg05123106) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.19E+00 | Statistic Test | p-value: 1.72E-05; Z-score: 4.32E+00 | ||
Methylation in Case |
8.06E-01 (Median) | Methylation in Control | 6.75E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A17 in bladder cancer | [ 3 ] | |||
Location |
3'UTR (cg27077316) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 8.89E-03; Z-score: 1.94E+00 | ||
Methylation in Case |
7.55E-01 (Median) | Methylation in Control | 6.26E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg23558213) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.86E+00 | Statistic Test | p-value: 4.74E-14; Z-score: 2.52E+00 | ||
Methylation in Case |
2.99E-01 (Median) | Methylation in Control | 1.61E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A17 in breast cancer | [ 4 ] | |||
Location |
TSS200 (cg03309838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 5.84E-03; Z-score: 4.28E-01 | ||
Methylation in Case |
2.50E-02 (Median) | Methylation in Control | 2.15E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A17 in breast cancer | [ 4 ] | |||
Location |
TSS200 (cg25201783) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 3.89E-02; Z-score: 3.70E-01 | ||
Methylation in Case |
5.85E-02 (Median) | Methylation in Control | 4.88E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A17 in breast cancer | [ 4 ] | |||
Location |
Body (cg05123106) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.24E-05; Z-score: 8.55E-01 | ||
Methylation in Case |
8.15E-01 (Median) | Methylation in Control | 7.72E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A17 in breast cancer | [ 4 ] | |||
Location |
Body (cg23013931) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 3.65E-03; Z-score: -4.38E-01 | ||
Methylation in Case |
7.29E-02 (Median) | Methylation in Control | 8.37E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A17 in breast cancer | [ 4 ] | |||
Location |
Body (cg10954454) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 3.93E-02; Z-score: -4.32E-01 | ||
Methylation in Case |
6.16E-01 (Median) | Methylation in Control | 6.52E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg26356892) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 6.55E-06; Z-score: 1.30E+00 | ||
Methylation in Case |
4.39E-02 (Median) | Methylation in Control | 3.56E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A17 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg15275890) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 3.29E-02; Z-score: -3.32E-01 | ||
Methylation in Case |
9.44E-01 (Median) | Methylation in Control | 9.49E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A17 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS200 (cg25201783) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 2.05E-02; Z-score: 4.53E-01 | ||
Methylation in Case |
2.12E-02 (Median) | Methylation in Control | 1.95E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A17 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
1stExon (cg16167174) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 4.03E-02; Z-score: 1.67E-01 | ||
Methylation in Case |
1.02E-02 (Median) | Methylation in Control | 9.94E-03 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A17 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg26688803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 2.10E-02; Z-score: 3.47E-01 | ||
Methylation in Case |
5.44E-02 (Median) | Methylation in Control | 5.17E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in colorectal cancer | [ 6 ] | |||
Location |
TSS1500 (cg15275890) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.53E-04; Z-score: -6.44E-01 | ||
Methylation in Case |
8.96E-01 (Median) | Methylation in Control | 9.06E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A17 in colorectal cancer | [ 6 ] | |||
Location |
TSS1500 (cg26356892) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 5.39E-03; Z-score: -7.72E-01 | ||
Methylation in Case |
1.13E-01 (Median) | Methylation in Control | 1.47E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A17 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg21694044) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 5.14E-06; Z-score: 9.33E-01 | ||
Methylation in Case |
8.41E-02 (Median) | Methylation in Control | 7.16E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A17 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg10954454) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 8.75E-08; Z-score: -1.67E+00 | ||
Methylation in Case |
6.60E-01 (Median) | Methylation in Control | 7.03E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A17 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg26548134) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.00E+00 | Statistic Test | p-value: 6.75E-03; Z-score: 3.48E-01 | ||
Methylation in Case |
9.44E-01 (Median) | Methylation in Control | 9.41E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A17 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg26688803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 3.30E-02; Z-score: 4.70E-01 | ||
Methylation in Case |
1.53E-01 (Median) | Methylation in Control | 1.47E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A17 in colorectal cancer | [ 6 ] | |||
Location |
Body (cg06342838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.00E+00 | Statistic Test | p-value: 3.58E-02; Z-score: 3.80E-01 | ||
Methylation in Case |
9.66E-01 (Median) | Methylation in Control | 9.64E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg15275890) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 8.91E-08; Z-score: -7.64E-01 | ||
Methylation in Case |
7.79E-01 (Median) | Methylation in Control | 8.26E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A17 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg23558213) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 1.83E-03; Z-score: -9.99E-01 | ||
Methylation in Case |
2.20E-01 (Median) | Methylation in Control | 2.72E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A17 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg23013931) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 2.07E-03; Z-score: -6.00E-01 | ||
Methylation in Case |
6.52E-02 (Median) | Methylation in Control | 6.97E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A17 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg05123106) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 2.35E-02; Z-score: -3.55E-02 | ||
Methylation in Case |
8.35E-01 (Median) | Methylation in Control | 8.36E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg23558213) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.56E+00 | Statistic Test | p-value: 2.05E-05; Z-score: 2.08E+00 | ||
Methylation in Case |
3.07E-01 (Median) | Methylation in Control | 1.96E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A17 in HIV infection | [ 8 ] | |||
Location |
Body (cg26548134) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 3.37E-03; Z-score: -8.33E-01 | ||
Methylation in Case |
7.48E-01 (Median) | Methylation in Control | 7.96E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A17 in HIV infection | [ 8 ] | |||
Location |
Body (cg23013931) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.15E-02; Z-score: -3.29E-01 | ||
Methylation in Case |
7.86E-02 (Median) | Methylation in Control | 8.20E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A17 in HIV infection | [ 8 ] | |||
Location |
Body (cg08157194) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.00E+00 | Statistic Test | p-value: 3.30E-02; Z-score: 2.15E-01 | ||
Methylation in Case |
8.99E-01 (Median) | Methylation in Control | 8.95E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A17 in HIV infection | [ 8 ] | |||
Location |
Body (cg26688803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 3.72E-02; Z-score: -4.37E-01 | ||
Methylation in Case |
8.81E-02 (Median) | Methylation in Control | 9.32E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A17 in HIV infection | [ 8 ] | |||
Location |
Body (cg05123106) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 3.88E-02; Z-score: -8.29E-01 | ||
Methylation in Case |
8.78E-01 (Median) | Methylation in Control | 9.03E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg26356892) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 2.85E-02; Z-score: -5.62E-01 | ||
Methylation in Case |
1.42E-01 (Median) | Methylation in Control | 1.61E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A17 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS200 (cg25201783) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 4.37E-02; Z-score: -3.37E-01 | ||
Methylation in Case |
7.09E-02 (Median) | Methylation in Control | 7.50E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in prostate cancer | [ 10 ] | |||
Location |
TSS1500 (cg15275890) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.03E-02; Z-score: 2.11E+00 | ||
Methylation in Case |
9.41E-01 (Median) | Methylation in Control | 9.16E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A17 in prostate cancer | [ 10 ] | |||
Location |
TSS200 (cg12799349) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.37E+00 | Statistic Test | p-value: 5.15E-04; Z-score: 5.09E+00 | ||
Methylation in Case |
1.30E-01 (Median) | Methylation in Control | 9.48E-02 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Depression |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in depression | [ 11 ] | |||
Location |
TSS200 (cg13836920) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 3.75E-02; Z-score: 3.86E-01 | ||
Methylation in Case |
3.77E-02 (Median) | Methylation in Control | 3.58E-02 (Median) | ||
Studied Phenotype |
Depression [ ICD-11: 6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
1stExon (cg16167174) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.80E+00 | Statistic Test | p-value: 4.78E-18; Z-score: 2.61E+00 | ||
Methylation in Case |
6.16E-01 (Median) | Methylation in Control | 3.42E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A17 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg03888645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.56E+00 | Statistic Test | p-value: 4.64E-04; Z-score: -4.80E-01 | ||
Methylation in Case |
8.19E-02 (Median) | Methylation in Control | 1.28E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A17 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg05123106) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 1.25E-03; Z-score: -7.58E-01 | ||
Methylation in Case |
8.09E-01 (Median) | Methylation in Control | 8.86E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A17 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg06342838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.54E+00 | Statistic Test | p-value: 2.30E-03; Z-score: -9.17E-01 | ||
Methylation in Case |
2.31E-01 (Median) | Methylation in Control | 3.56E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A17 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg08157194) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 5.45E-03; Z-score: 2.68E-01 | ||
Methylation in Case |
9.16E-01 (Median) | Methylation in Control | 8.81E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A17 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
Body (cg10954454) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 1.93E-02; Z-score: 8.24E-01 | ||
Methylation in Case |
6.63E-01 (Median) | Methylation in Control | 5.42E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A17 in atypical teratoid rhabdoid tumor | [ 12 ] | |||
Location |
3'UTR (cg27077316) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 3.29E-09; Z-score: -1.56E+00 | ||
Methylation in Case |
7.29E-01 (Median) | Methylation in Control | 8.08E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in panic disorder | [ 13 ] | |||
Location |
1stExon (cg16167174) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 9.89E-01 | Statistic Test | p-value: 2.78E-02; Z-score: 2.42E-01 | ||
Methylation in Case |
-5.46E+00 (Median) | Methylation in Control | -5.52E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A17 in panic disorder | [ 13 ] | |||
Location |
Body (cg08157194) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 2.63E-02; Z-score: 1.91E-01 | ||
Methylation in Case |
3.06E+00 (Median) | Methylation in Control | 2.98E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A17 in systemic lupus erythematosus | [ 14 ] | |||
Location |
Body (cg26688803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 3.14E-02; Z-score: -2.06E-01 | ||
Methylation in Case |
1.10E-01 (Median) | Methylation in Control | 1.14E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-196a directly targets SLC25A17 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-196a | miRNA Mature ID | miR-196a-5p | ||
miRNA Sequence |
UAGGUAGUUUCAUGUUGUUGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 2 |
miR-2276 directly targets SLC25A17 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-2276 | miRNA Mature ID | miR-2276-5p | ||
miRNA Sequence |
GCCCUCUGUCACCUUGCAGACG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 3 |
miR-4433a directly targets SLC25A17 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4433a | miRNA Mature ID | miR-4433a-3p | ||
miRNA Sequence |
ACAGGAGUGGGGGUGGGACAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 4 |
miR-4469 directly targets SLC25A17 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4469 | miRNA Mature ID | miR-4469 | ||
miRNA Sequence |
GCUCCCUCUAGGGUCGCUCGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 5 |
miR-4496 directly targets SLC25A17 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4496 | miRNA Mature ID | miR-4496 | ||
miRNA Sequence |
GAGGAAACUGAAGCUGAGAGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 6 |
miR-4768 directly targets SLC25A17 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4768 | miRNA Mature ID | miR-4768-3p | ||
miRNA Sequence |
CCAGGAGAUCCAGAGAGAAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 7 |
miR-526b directly targets SLC25A17 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-526b | miRNA Mature ID | miR-526b-5p | ||
miRNA Sequence |
CUCUUGAGGGAAGCACUUUCUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 8 |
miR-642a directly targets SLC25A17 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-642a | miRNA Mature ID | miR-642a-5p | ||
miRNA Sequence |
GUCCCUCUCCAAAUGUGUCUUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 9 |
miR-6892 directly targets SLC25A17 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6892 | miRNA Mature ID | miR-6892-3p | ||
miRNA Sequence |
UCCCUCUCCCACCCCUUGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 10 |
miR-766 directly targets SLC25A17 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-766 | miRNA Mature ID | miR-766-5p | ||
miRNA Sequence |
AGGAGGAAUUGGUGCUGGUCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.